nach oben

06.01.2018 | Original Article | Ausgabe 6/2017

Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association

Zeitschrift:: Indian Journal of Gastroenterology > Ausgabe 6/2017

Autoren:: Saurabh Kedia, Raju Sharma, Govind K. Makharia, Vineet Ahuja, Devendra Desai, Devasenathipathy Kandasamy, Anu Eapen, Karthik Ganesan, Uday C. Ghoshal, Naveen Kalra, D. Karthikeyan, Kumble Seetharama Madhusudhan, Mathew Philip, Amarender Singh Puri, Sunil Puri, Saroj K. Sinha, Rupa Banerjee, Shobna Bhatia, Naresh Bhat, Sunil Dadhich, G. K. Dhali, B. D. Goswami, S. K. Issar, V. Jayanthi, S. P. Misra, Sandeep Nijhawan, Pankaj Puri, Avik Sarkar, S. P. Singh, Anshu Srivastava, Philip Abraham, B. S. Ramakrishna, for Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease

Abstract

The Indian Society of Gastroenterology (ISG) Task Force on Inflammatory Bowel Disease and the Indian Radiological and Imaging Association (IRIA) developed combined ISG-IRIA evidence-based best-practice guidelines for imaging of the small intestine in patients with suspected or known Crohn’s disease. These 29 position statements, developed through a modified Delphi process, are intended to serve as reference for teaching, clinical practice, and research.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

★ PREMIUM-INHALT

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Jetzt e.Med bestellen und 100 € sparen!

Jetzt gratis testen * Jetzt kaufen

Sie können e.Med Interdisziplinär 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt testen ¹

Ramakrishna BS, Makharia GK, Abraham P, et al. Indian Society of Gastroenterology consensus on ulcerative colitis. Indian J Gastroenterol. 2012;31:307–23.

Ramakrishna BS, Makharia GK, Ahuja V, et al. Indian Society of Gastroenterology consensus statements on Crohn’s disease in India. Indian J Gastroenterol. 2015;34:3–22.

Linstone H, Turoff M. The Delphi method: techniques and application. Available at https://web.njit.edu/~turoff/pubs/delphibook/delphibook.pdf. Accessed on 26.12.2017.

The periodic health examination: 2. 1984 update. Canadian Task Force on the Periodic Health Examination. Can Med Assoc J. 1984;130:1278–85.

Makharia GK, Ramakrishna BS, Abraham P, et al. Survey of inflammatory bowel diseases in India. Indian J Gastroenterol. 2012;31:299–306.

Magro F, Gionchetti P, Eliakim R, et al. European Crohn’s and Colitis Organisation [ECCO]. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649–70.

Yang DH, Keum B, Jeen YT. Capsule endoscopy for Crohn’s disease: current status of diagnosis and management. Gastroenterol Res Pract. 2016;2016:8236367.

Kelvin FM, Gedgaudas RK. Radiologic diagnosis of Crohn disease (with emphasis on its early manifestations). Crit Rev Diagn Imaging. 1981;16:43–91.

Nolan DJ. Radiology of Crohn’s disease of the small intestine: a review. J R Soc Med. 1981;74:294–300.

10.

Bernstein CN, Boult IF, Greenberg HM, van der Putten W, Duffy G, Grahame GR. A prospective randomized comparison between small bowel enteroclysis and small bowel follow-through in Crohn’s disease. Gastroenterology. 1997;113:390–8.

11.

Bernstein CN, Greenberg H, Boult I, Chubey S, Leblanc C, Ryner L. A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn’s disease. Am J Gastroenterol. 2005;100:2493–502.

12.

Hara AK, Leighton JA, Heigh RI, et al. disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology 2006;238:128–34.

13.

Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology. 2009;251:751–61.

14.

Albert JG, Martiny F, Krummenerl A, et al. Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut. 2005;54:1721–7.

15.

Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H. Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology. 2000;215:717–25.

16.

Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M. Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol. 2004;14:1017–24.

17.

Masselli G, Casciani E, Polettini E, Lanciotti S, Bertini L, Gualdi G. Assessment of Crohn’s disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis. Eur Radiol. 2006;16:2817–27.

18.

Wold PB, Fletcher JG, Johnson CD, Sandborn WJ. Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy—feasibility study. Radiology. 2003;229:275–81.

19.

Ryan ER, Heaslip ISE. Magnetic resonance enteroclysis compared with conventional enteroclysis and computed tomography enteroclysis: a critically appraised topic. Abdom Imaging. 2008;33:34–7.

20.

Reittner P, Goritschnig T, Petritsch W, et al. Multiplanar spiral CT enterography in patients with Crohn’s disease using a negative oral contrast material: initial results of a noninvasive imaging approach. Eur Radiol. 2002;12:2253–7.

21.

Horsthuis K, Lavini C, Stoker J. MRI in Crohn’s disease. J Magn Reson Imaging. 2005;22:1–12.

22.

Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn’s disease, the oral contrast method and MR enteroclysis. Eur Radiol. 2007;17:2294–301.

23.

Schreyer AG, Geissler A, Albrich H, et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn’s disease. Clin Gastroenterol Hepatol. 2004;2:491–7.

24.

Masselli G, Casciani E, Polettini E, Gualdi G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn’s disease. Eur Radiol. 2008;18:438–47.

25.

Dave-Verma H, Moore S, Singh A, Martins N, Zawacki J. Computed tomographic enterography and enteroclysis: pearls and pitfalls. Curr Probl Diagn Radiol. 2008;37:279–87.

26.

Paparo F, Garlaschi A, Biscaldi E, Bacigalupo L, Cevasco L, Rollandi GA. Computed tomography of the bowel: a prospective comparison study between four techniques. Eur J Radiol. 2013;82:e1–10.

27.

Minordi LM, Vecchioli A, Mirk P, Bonomo L. CT enterography with polyethylene glycol solution vs CT enteroclysis in small bowel disease. Br J Radiol. 2011;84:112–9.

28.

Qi F, Jun S, Qi QY, et al. Utility of the diffusion-weighted imaging for activity evaluation in Crohn’s disease patients underwent magnetic resonance enterography. BMC Gastroenterol. 2015;15:12.

29.

Kim KJ, Lee Y, Park SH, et al. Diffusion-weighted MR enterography for evaluating Crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis. 2015;21:101–9.

30.

Choi SH, Kim KW, Lee JY, Kim KJ, Park SH. Diffusion-weighted magnetic resonance enterography for evaluating bowel inflammation in Crohn’s disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2016;22:669–79.

31.

Grand DJ, Beland MD, Machan JT, Mayo-Smith WW. Detection of Crohn’s disease: comparison of CT and MR enterography without anti-peristaltic agents performed on the same day. Eur J Radiol. 2012;81:1735–41.

32.

Jensen MD, Kjeldsen J, Rafaelsen SR, Nathan T. Diagnostic accuracies of MR enterography and CT enterography in symptomatic Crohn’s disease. Scand J Gastroenterol. 2011;46:1449–57.

33.

Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn’s disease. AJR Am J Roentgenol 2009;193:113–21.

34.

Qiu Y, Mao R, Chen BL, et al. Systematic review with meta-analysis: magnetic resonance enterography vs. computed tomography enterography for evaluating disease activity in small bowel Crohn’s disease. Aliment Pharmacol Ther. 2014;40:134–46.

35.

Amitai MM, Raviv-Zilka L, Hertz M, et al. Main imaging features of Crohn’s disease: agreement between MR-enterography and CT-enterography. Isr Med Assoc J. 2015;17:293–7.

36.

Ippolito D, Invernizzi F, Galimberti S, Panelli MR, Sironi S. MR enterography with polyethylene glycol as oral contrast medium in the follow-up of patients with Crohn disease: comparison with CT enterography. Abdom Imaging. 2010;35:563–70.

37.

Quencer KB, Nimkin K, Mino-Kenudson M, Gee MS. Detecting active inflammation and fibrosis in pediatric Crohn’s disease: prospective evaluation of MR-E and CT-E. Abdom Imaging. 2013;38:705–13.

38.

Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis. 2011;17:1073–80.

39.

Jensen MD, Ormstrup T, Vagn-Hansen C, Østergaard L, Rafaelsen SR. Interobserver and intermodality agreement for detection of small bowel Crohn’s disease with MR enterography and CT enterography. Inflamm Bowel Dis. 2011;17:1081–8.

40.

Masselli G, Gualdi GCT. MR enterography in evaluating small bowel diseases: when to use which modality? Abdom Imaging. 2013;38:249–59.

41.

Kim AY. Role of computed tomography enterography/magnetic resonance enterography: is it in prime time? Clin Endosc. 2012;45:269–73.

42.

Sodickson A, Baeyens PF, Andriole KP, et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology. 2009;251:175–84.

43.

Kotlyar DS, Lewis JD, Beaugerie L, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol. 2015; 13:847-58.e4; quiz e48-50.

44.

Kroeker KI, Lam S, Birchall I, Fedorak RN. Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study. J Clin Gastroenterol. 2011;45:34–9.

45.

Sauer CG, Kugathasan S, Martin DR, Applegate KE. Medical radiation exposure in children with inflammatory bowel disease estimates high cumulative doses. Inflamm Bowel Dis. 2011;17:2326–32.

46.

Peloquin JM, Pardi DS, Sandborn WJ, et al. Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:2015–22.

47.

Palmer L, Herfarth H, Porter CQ, Fordham LA, Sandler RS, Kappelman MD. Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases. Am J Gastroenterol. 2009;104:2816–23.

48.

Englund H, Lidén KK, Lind T, Sundström T, Karling P. Radiation exposure in patients with inflammatory bowel disease and irritable bowel syndrome in the years 2001–2011. Scand J Gastroenterol. 2017;52:300–5.

49.

Masselli G, Mastroiacovo I, De Marco E, et al. Current tecniques and new perpectives research of magnetic resonance enterography in pediatric Crohn’s disease. World J Radiol. 2016;8:668–82.

50.

Schreyer AG, Hoffstetter P, Daneschnejad M, et al. Comparison of conventional abdominal CT with MR-enterography in patients with active Crohn’s disease and acute abdominal pain. Acad Radiol. 2010;17:352–7.

51.

Greenup AJ, Bressler B, Rosenfeld G. Medical imaging in small bowel Crohn’s disease—computer tomography enterography, magnetic resonance enterography, and ultrasound: “which one is the best for what?”. Inflamm Bowel Dis. 2016;22:1246–61.

52.

Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn’s disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009;54:1099–107.

53.

Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A:5A–36A.

54.

Vermeire S, Van Assche G, Rutgeerts P. Classification of inflammatory bowel disease: the old and the new. Curr Opin Gastroenterol. 2012;28:321–6.

55.

Ooi CJ, Makharia GK, Hilmi I, et al. Asia Pacific Consensus Statements on Crohn’s disease. Part 1: definition, diagnosis, and epidemiology: (Asia Pacific Crohn’s Disease Consensus—Part 1). J Gastroenterol Hepatol. 2016;31:45–55.

56.

Ghoshal UC, Lakshmi CP, Kumar S, et al. Capsule endoscopy for obscure gastrointestinal bleeding in the tropics: report from India. Dig Endosc. 2011;23:17–23.

57.

Chu Y, Wu S, Qian Y, et al. Complimentary imaging modalities for investigating obscure gastrointestinal bleeding: capsule endoscopy, double-balloon enteroscopy, and computed tomographic enterography. Gastroenterol Res Pract. 2016;2016:8367519.

58.

Triester SL, Leighton JA, Leontiadis GI, et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn’s disease. Am J Gastroenterol 2006;101:954–64.

59.

Ma JJ, Wang Y, Xu XM, et al. Capsule endoscopy and single-balloon enteroscopy in small bowel diseases: competing or complementary? World J Gastroenterol. 2016;22:10625–30.

60.

Annunziata ML, Caviglia R, Papparella LG, Cicala M. Upper gastrointestinal involvement of Crohn’s disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci. 2012;57:1618–23.

61.

Hummel TZ, ten Kate FJW, Reitsma JB, Benninga MA, Kindermann A. Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBD. J Pediatr Gastroenterol Nutr. 2012;54:753–7.

62.

Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg. 1976;63:1–12.

63.

Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology 2001;121:1064–72.

64.

Kim DH, Carucci LR, Baker ME, et al. ACR Appropriateness criteria Crohn disease. J Am Coll Radiol. 2015;12:1048–57.e4.

65.

Madureira AJ. The comb sign. Radiology. 2004;230:783–4.

66.

Booya F, Fletcher JG, Huprich JE, et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology 2006;241:787–95.

67.

Bodily KD, Fletcher JG, Solem CA, et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography—correlation with endoscopic and histologic findings of inflammation. Radiology 2006;238:505–16.

68.

Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assessment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut. 2006;55:1561–7.

69.

Wu YW, Tao XF, Tang YH, Hao NX, Miao F. Quantitative measures of comb sign in Crohn’s disease: correlation with disease activity and laboratory indications. Abdom Imaging. 2012;37:350–8. CrossRefPubMed

70.

Lo Re G, Cappello M, Tudisca C, et al. CT enterography as a powerful tool for the evaluation of inflammatory activity in Crohn’s disease: relationship of CT findings with CDAI and acute-phase reactants. Radiol Med. 2014;119:658–66.

71.

Puylaert CA, Tielbeek JA, Bipat S, Stoker J. Grading of Crohn’s disease activity using CT, MRI, US and scintigraphy: a meta-analysis. Eur Radiol. 2015;25:3295–313.

72.

Church PC, Turner D, Feldman BM, et al. Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn’s disease. Aliment Pharmacol Ther. 2015;41:153–66.

73.

Westerland O, Griffin N. Magnetic resonance enterography in Crohn’s disease. Semin Ultrasound CT MR. 2016;37:282–91.

74.

Rimola J, Rodriguez S, García-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–20.

75.

Buisson A, Joubert A, Montoriol PF, et al. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn’s disease. Aliment Pharmacol Ther. 2013;37:537–45.

76.

Hordonneau C, Buisson A, Scanzi J, et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn’s disease: validation of quantitative index of activity. Am J Gastroenterol. 2014;109:89–98.

77.

Tolan DJM, Greenhalgh R, Zealley IA, Halligan S, Taylor SA. MR enterographic manifestations of small bowel Crohn disease. Radiographics. 2010;30:367–84.

78.

Rimola J, Ordás I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn’s disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis. 2011;17:1759–68.

79.

Kim JS, Jang HY, Park SH, et al. MR enterography assessment of bowel inflammation severity in Crohn disease using the MR index of activity score: modifying roles of DWI and effects of contrast phases. AJR Am J Roentgenol. 2017;208:1022–9.

80.

Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013;7:982–1018.

81.

Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–50.

82.

Chan G, Fefferman DS, Farrell RJ. Endoscopic assessment of inflammatory bowel disease: colonoscopy/esophagogastroduodenoscopy. Gastroenterol Clin N Am. 2012;41:271–90.

83.

Huang LC, Merchea A. Dysplasia and cancer in inflammatory bowel disease. Surg Clin North Am. 2017;97:627–39.

84.

Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated by strictures: a systematic review. Gut. 2013;62:1072–84.

85.

Rimola J, Planell N, Rodríguez S, et al. Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–40.

86.

Maccioni F, Staltari I, Pino AR, Tiberti A. Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohn’s disease. Abdom Imaging. 2012;37:944–57.

87.

Tielbeek JAW, Ziech MLW, Li Z, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol. 2014;24:619–29.

88.

Moy MP, Kaplan JL, Moran CJ, Winter HS, Gee MS. MR enterographic findings as biomarkers of mucosal healing in young patients with Crohn disease. AJR Am J Roentgenol. 2016:1–7. [Epub ahead of print].

89.

Fornasa F, Benassuti C, Benazzato L. Role of magnetic resonance enterography in differentiating between fibrotic and active inflammatory small bowel stenosis in patients with Crohn’s disease. J Clin Imaging Sci. 2011;1:35.

90.

Pazahr S, Blume I, Frei P, et al. Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn’s disease: initial experience. MAGMA. 2013;26:291–301.

91.

Panés J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34:125–45.

92.

Malagò R, D’Onofrio M, Mantovani W, et al. Contrast-enhanced ultrasonography (CEUS) vs. MRI of the small bowel in the evaluation of Crohn’s disease activity. Radiol Med. 2012;117:268–81.

93.

Ripollés T, Rausell N, Paredes JM, Grau E, Martínez MJ, Vizuete J. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis. J Crohns Colitis. 2013;7:120–8.

94.

Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777–82.

95.

Booya F, Akram S, Fletcher JG, et al. CT enterography and fistulizing Crohn’s disease: clinical benefit and radiographic findings. Abdom Imaging. 2009;34:467–75.

96.

Leardi S, Simi M, Verde B, et al. Diagnostic and therapeutic problems of non perianal fistulas and abscesses in Crohn’s disease. Ital J Surg Sci. 1988;18:247–52.

97.

Galia M, Agnello F, La Grutta L, et al. Computed tomography of bowel obstruction: tricks of the trade. Expert Rev Gastroenterol Hepatol. 2015;9:1115–25.

98.

Smida M, Miloudi N, Hefaiedh R, Zaibi R. Emergency surgery for Crohn’s disease. Tunis Med. 2016;94:210–5.

99.

Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.

100.

Gionchetti P, Dignass A, Danese S, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 2: Surgical management and special situations. J Crohns Colitis. 2017;11:135–49.

101.

Pesce Lamas Constantino C, Souza Rodrigues R, Araujo Oliveira Neto J, et al. Computed tomography and magnetic resonance enterography findings in Crohn’s disease: what does the clinician need to know from the radiologist? Can Assoc Radiol J. 2014;65:42–51. CrossRefPubMed

102.

Maconi G, Sampietro GM, Parente F, et al. Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study. Am J Gastroenterol. 2003;98:1545–55.

103.

Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 1: Diagnosis and medical management. J Crohns Colitis. 2017;11:3–25.

104.

Hellers G, Bergstrand O, Ewerth S, Holmström B. Occurrence and outcome after primary treatment of anal fistulae in Crohn’s disease. Gut. 1980;21:525–7.

105.

Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 2013;7:556–85.

106.

Shenoy-Bhangle A, Nimkin K, Goldner D, Bradley WF, Israel EJ, Gee MS. MRI predictors of treatment response for perianal fistulizing Crohn disease in children and young adults. Pediatr Radiol. 2014;44:23–9.

107.

Siddiqui MRS, Ashrafian H, Tozer P, et al. A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Dis Colon Rectum. 2012;55:576–85.

108.

Maconi G, Tonolini M, Monteleone M, et al. Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn’s disease. Inflamm Bowel Dis. 2013;19:2737–43.

109.

Ng SC, Plamondon S, Gupta A, et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn’s perineal fistulas. Am J Gastroenterol. 2009;104:2973–86.

110.

Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn’s disease. Am J Gastroenterol. 2003;98:332–9.

111.

Karmiris K, Bielen D, Vanbeckevoort D, et al. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn’s disease by using magnetic resonance imaging. Clin Gastroenterol Hepatol 2011;9:130–6.

112.

Schnitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease. Inflamm Bowel Dis 2009;15:1295–301.

113.

Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastroenterology. 2010;138:463–8. quiz e10–1 CrossRefPubMed

114.

Benitez JM, Meuwis MA, Reenaers C, Van Kemseke C, Meunier P, Louis E. Role of endoscopy, cross-sectional imaging and biomarkers in Crohn’s disease monitoring. Gut. 2013;62:1806–16.

115.

Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247:64–79.

116.

Serafin Z, Białecki M, Białecka A, Sconfienza LM, Kłopocka M. Contrast-enhanced ultrasound for detection of Crohn’s disease activity: systematic review and meta-analysis. J Crohns Colitis. 2016;10:354–62.

117.

Gallego Ojea JC, Echarri Piudo AI, Porta Vila A. Crohn’s disease: the usefulness of MR enterography in the detection of recurrence after surgery. Australas Radiol. 2011;53:552–9.

118.

Sailer J, Peloschek P, Reinisch W, Vogelsang H, Turetschek K, Schima W. Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy. Eur Radiol. 2008;18:2512–21.

119.

Mao R, Gao X, Zhu Z, et al. CT enterography in evaluating postoperative recurrence of Crohn’s disease after ileocolic resection: complementary role to endoscopy. Inflamm Bowel Dis. 2013;19:977–82.

120.

Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015;372:2127–35.

121.

Wong SH, Ip M, Tang W, et al. Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:2067–72.

122.

Papay P, Eser A, Winkler S, et al. Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:84–90.

123.

Andrisani G, Armuzzi A, Papa A, et al. Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. J Gastrointest Liver Dis. 2013;22:21–5.

124.

Abitbol Y, Laharie D, Cosnes J, et al. Negative screening does not rule out the risk of tuberculosis in patients with inflammatory bowel disease undergoing anti-TNF treatment: a descriptive study on the GETAID cohort. J Crohns Colitis. 2016;10:1179–85.

125.

Debeuckelaere C, De Munter P, Van Bleyenbergh P, et al. Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening. J Crohns Colitis. 2014;8:550–7.

126.

Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098–104.

127.

Piccazzo R, Paparo F, Garlaschi G. Diagnostic accuracy of chest radiography for the diagnosis of tuberculosis (TB) and its role in the detection of latent TB infection: a systematic review. J Rheumatol Suppl. 2014;91:32–40.

128.

Lyu J, Lee SG, Hwang S, et al. Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates. Liver Transplant. 2011;17:963–8.

129.

Hirama T, Hagiwara K, Kanazawa M. Tuberculosis screening programme using the QuantiFERON-TB Gold test and chest computed tomography for healthcare workers accidentally exposed to patients with tuberculosis. J Hosp Infect. 2011;77:257–62.

130.

Song DJ, Tong JL, Peng JC, et al. Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: a retrospective study. J Dig Dis. 2017;18:23–30.

131.

Makharia GK, Srivastava S, Das P, et al. Clinical, endoscopic, and histological differentiations between Crohn’s disease and intestinal tuberculosis. Am J Gastroenterol. 2010;105:642–51.

132.

Yu H, Liu Y, Wang Y, Peng L, Li A, Zhang Y. Clinical, endoscopic and histological differentiations between Crohn’s disease and intestinal tuberculosis. Digestion. 2012;85:202–9.

133.

Lee YJ, Yang SK, Byeon JS, et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn’s disease. Endoscopy. 2006;38:592–7.

134.

Pulimood AB, Peter S, Rook GWA, Donoghue HD. In situ PCR for Mycobacterium tuberculosis in endoscopic mucosal biopsy specimens of intestinal tuberculosis and Crohn disease. Am J Clin Pathol. 2008;129:846–51.

135.

Kirsch R, Pentecost M, Hall Pde M, Epstein DP, Watermeyer G, Friederich PW. Role of colonoscopic biopsy in distinguishing between Crohn’s disease and intestinal tuberculosis. J Clin Pathol. 2006;59:840–4.

136.

Jin XJ, Kim JM, Kim HK, et al. Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn’s disease. World J Gastroenterol. 2010;16:2496–503.

137.

Amarapurkar DN, Patel ND, Rane PS. Diagnosis of Crohn’s disease in India where tuberculosis is widely prevalent. World J Gastroenterol. 2008;14:741–6.

138.

Logan VS. Anorectal tuberculosis. Proc R Soc Med. 1969;62:1227–30.

139.

Kedia S, Sharma R, Nagi B, et al. Computerized tomography-based predictive model for differentiation of Crohn’s disease from intestinal tuberculosis. Indian J Gastroenterol. 2015;34:135–43.

140.

Mao R, Liao W, He Y, et al. Computed tomographic enterography adds value to colonoscopy in differentiating Crohn’s disease from intestinal tuberculosis: a potential diagnostic algorithm. Endoscopy. 2015;47:322–9.

141.

Zhao XS, Wang ZT, Wu ZY, et al. Differentiation of Crohn’s disease from intestinal tuberculosis by clinical and CT enterographic models. Inflamm Bowel Dis. 2014;20:916–25.

142.

Krishna S, Kalra N, Singh P, et al. Small-bowel tuberculosis: a comparative study of MR enterography and small-bowel follow-through. AJR Am J Roentgenol. 2016;207:571–7.

143.

Zhao J, Cui MY, Chan T, et al. Evaluation of intestinal tuberculosis by multi-slice computed tomography enterography. BMC Infect Dis. 2015;15:577.

144.

Bhargava S, Kumar P, Bhargava SK. Role of multislice CT in abdominal tuberculosis. J Int Med Sci Acad. 2013;26:47–50.

145.

Gourtsoyianni S, Papanikolaou N, Amanakis E, et al. Crohn’s disease lymphadenopathy: MR imaging findings. Eur J Radiol. 2009;69:425–8.

146.

Burrill J, Williams CJ, Bain G, Conder G, Hine AL, Misra RR. Tuberculosis: a radiologic review. Radiographics. 2007;27:1255–73.

147.

Leder RA, Low VH. Tuberculosis of the abdomen. Radiol Clin N Am. 1995;33:691–705.

148.

Kedia S, Sharma R, Sreenivas V, et al. Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn’s disease: a systematic review with meta-analysis. Intest Res. 2017;15:149–59.

149.

Park YH, Chung WS, Lim JS, et al. Diagnostic role of computed tomographic enterography differentiating Crohn disease from intestinal tuberculosis. J Comput Assist Tomogr. 2013;37:834–9.

150.

Limsrivilai J, Shreiner AB, Pongpaibul A, et al. Meta-analytic Bayesian model for differentiating intestinal tuberculosis from Crohn’s disease. Am J Gastroenterol. 2017;112:415–27.

151.

Yadav DP, Madhusudhan KS, Kedia S, et al. Development and validation of visceral fat quantification as a surrogate marker for differentiation of Crohn’s disease and intestinal tuberculosis. J Gastroenterol Hepatol. 2017;32:420–6.

152.

Ko JK, Lee HL, Kim JO, et al. Visceral fat as a useful parameter in the differential diagnosis of Crohn’s disease and intestinal tuberculosis. Intest Res. 2014;12:42–7.

Titel: Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association
Autoren:: Saurabh Kedia
Raju Sharma
Govind K. Makharia
Vineet Ahuja
Devendra Desai
Devasenathipathy Kandasamy
Anu Eapen
Karthik Ganesan
Uday C. Ghoshal
Naveen Kalra
D. Karthikeyan
Kumble Seetharama Madhusudhan
Mathew Philip
Amarender Singh Puri
Sunil Puri
Saroj K. Sinha
Rupa Banerjee
Shobna Bhatia
Naresh Bhat
Sunil Dadhich
G. K. Dhali
B. D. Goswami
S. K. Issar
V. Jayanthi
S. P. Misra
Sandeep Nijhawan
Pankaj Puri
Avik Sarkar
S. P. Singh
Anshu Srivastava
Philip Abraham
B. S. Ramakrishna
for Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease
Publikationsdatum: 06.01.2018
DOI: https://doi.org/10.1007/s12664-017-0804-y
Verlag: Springer India
Zeitschrift: Indian Journal of Gastroenterology
Ausgabe 6/2017
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711

Ich möchte die nächsten 2 Hefte kostenlos testen.

Sollte ich von der Zeitschrift nicht überzeugt sein, teile ich Ihnen dies bis spätestens 14 Tage nach Erhalt des zweiten Heftes mit.
Wenn ich die Zeitschrift weiterlesen möchte, brauche ich nichts zu tun und bekomme dann das Jahresabonnement dieser Zeitschrift zum Gesamtpreis von 78,98 € im Inland (Abonnementpreis 58,98 € plus Versandkosten 20,00 €) bzw. 86,98 € im Ausland (Abonnementpreis 58,98 € plus Versandkosten 28,00 €).
Dies entspricht einem Gesamtmonatspreis von 6,58 € im Inland bzw. 7,25 € im Ausland.

Die Abrechnung erfolgt einmal jährlich zu Beginn des Bezugszeitraumes per Rechnung.

Alle genannten Preise verstehen sich inklusiver deutscher gesetzlicher Mehrwertsteuer.
In EU-Ländern gilt die jeweilige gesetzliche Mehrwertsteuer. Dadurch kann es ggf. zu Preisabweichungen bei Bestellungen aus dem Ausland kommen.

Die Mindestlaufzeit dieses Abonnements beträgt ein Jahr. Wenn das Jahresabonnement nicht bis spätestens 30 Tage vor Ende des Bezugszeitraumes gekündigt wird, verlängert es sich automatisch jeweils um ein weiteres Jahr.

Es gilt das gesetzliche Mängelhaftungsrecht.
Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

Neu im Fachgebiet Innere Medizin

27.02.2020 | Covid-19 | Nachrichten

Imaging of the small intestine in Crohn’s disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Innere Medizin

Zahlreiche Quarantäne-Maßnahmen nach ersten Corona-Fällen

Oberarzt in Tübingen mit Coronavirus infiziert

EU-Länder sollen Pandemie-Pläne zu SARS-CoV-2 überarbeiten

Coronavirus: „Kliniken sollten Behandlungskapazitäten melden!“

Rheumatologie aus der Praxis

Ambulant erworbene Pneumonie

Newsletter

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Innere Medizin

Weitere Artikel der Ausgabe 6/2017

A tandem approach of tTGA testing: A new approach for celiac disease screening

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of pseudomyxoma peritonei: A single-center experience

Sequential testing with different tissue transglutaminase antibodies, a new approach for diagnosis of celiac disease

Multi-center prospective survey of inflammatory bowel diseases in Kerala: More than 2000 cases

Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver

Looking back: The Indian Journal of Gastroenterology 2012–2017

Neu im Fachgebiet Innere Medizin

Zahlreiche Quarantäne-Maßnahmen nach ersten Corona-Fällen

Oberarzt in Tübingen mit Coronavirus infiziert

EU-Länder sollen Pandemie-Pläne zu SARS-CoV-2 überarbeiten

Coronavirus: „Kliniken sollten Behandlungskapazitäten melden!“

Meistgelesene Bücher aus der Inneren Medizin

Rheumatologie aus der Praxis

Ambulant erworbene Pneumonie

Newsletter